Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Peer Review reports

Original Submission
21 Apr 2022	Submitted	Original manuscript
10 Jun 2022	Reviewed	Reviewer Report - Alexander Gough
5 Aug 2022	Author responded	Author comments - Mieke van Schaik
Resubmission - Version 2
5 Aug 2022	Submitted	Manuscript version 2
8 Aug 2022	Reviewed	Reviewer Report - Alexander Gough
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
22 Oct 2022	Editorially accepted
12 Nov 2022	Article published	10.1186/s13063-022-06874-w

Back to article page